Skip to main content
. 2021 Jul 5;7(7):e07475. doi: 10.1016/j.heliyon.2021.e07475

Table 2.

Fibromyalgia patients' responses of clinical trial awareness and participation in RCTs.

Overall 1
481 (100%)
Non-Underrepresented 1
313 (65.07%)
Underrepresented 1
168 (34.93%)
p -value2
Clinical trial awareness
Has your physician talked to you about clinical trials?
Yes 47 (10.71%) 33 (11.26%) 14 (9.59%) 0.593
No
392 (89.29%)
260 (88.74%)
132 (90.41%)

Have you ever been asked to participate in clinical trials?
Yes 65 (13.63%) 42 (13.46%) 23 (13.94%) 0.885
No
412 (86.37%)
270 (86.54%)
142 (86.06%)

How likely would you be to participate in RCTs?
Likely or very likely 410 (85.77%) 277 (88.78%) 133 (80.12%) 0.01
Not sure, not likely or would not participate
68 (14.23%)
35 (11.22%)
33 (19.88%)

Participation in Clinical trials
Yes 53 (11.09%) 35 (11.22%) 18 (10.84%) 0.99
No
425 (88.91%)
277 (88.78%)
148 (89.16%)

Trial experience
I took part and am still in the trial 5 (4.03%) 3 (4.05%) 2 (4.0%) 0.971
I took part and completed the trial 39 (31.45%) 25 (33.78%) 14 (28.0%)
I took part but withdrew before the end 2 (1.61%) 1 (1.35%) 1 (2.0%)
I wanted to take part but was not eligible 45 (36.29%) 26 (35.14%) 21 (38.0%)
I declined to take part in the trial 33 (26.61%) 19 (25.68%) 14 (28.0%)
1

Mean (SD) or Frequency (%).

2

Fisher's exact test; or t-test.